SNCA and Parkinson disease: In Parkinson’s disease, aberrant glycation of the toxic substrate α-synuclein enhances its pathogenicity by promoting both direct genomic damage through nuclear interactions and increased production of reactive oxygen species (ROS), ultimately leading to neuronal cell death [83].